# Detecting Colorectal Cancer With Liver Metastatic Lesions Using Novel Precise Imaging Tools

> **NCT06935149** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Primo Biotechnology Co., Ltd** · enrollment: 5 (estimated)

## Conditions studied

- Liver Metastasis Colon Cancer

## Interventions

- **DRUG:** 18-PSMA

## Key facts

- **NCT ID:** NCT06935149
- **Lead sponsor:** Primo Biotechnology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935149, "Detecting Colorectal Cancer With Liver Metastatic Lesions Using Novel Precise Imaging Tools". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06935149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*